Literature DB >> 31024090

Gastrointestinal motility, dysbiosis and opioid-induced tolerance: is there a link?

Hamid I Akbarali1, William L Dewey2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31024090      PMCID： PMC7045338          DOI： 10.1038/s41575-019-0150-x

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

Review 1.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

Review 2.  The gut-brain interaction in opioid tolerance.

Authors:  Hamid I Akbarali; William L Dewey
Journal:  Curr Opin Pharmacol       Date:  2017-11-13       Impact factor: 5.547

3.  Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis.

Authors:  C Acharya; N S Betrapally; P M Gillevet; R K Sterling; H Akbarali; M B White; D Ganapathy; A Fagan; M Sikaroodi; J S Bajaj
Journal:  Aliment Pharmacol Ther       Date:  2016-11-20       Impact factor: 8.171

4.  The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1).

Authors:  Timothy J Bell; Sunil J Panchal; Christine Miaskowski; Susan C Bolge; Tsveta Milanova; Russell Williamson
Journal:  Pain Med       Date:  2008-08-18       Impact factor: 3.750

5.  Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry.

Authors:  Gary R Lichtenstein; Brian G Feagan; Russell D Cohen; Bruce A Salzberg; Robert H Diamond; Samiyeh Price; Wayne Langholff; Anil Londhe; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2012-08-14       Impact factor: 10.864

6.  Bacterial Diversity of Intestinal Microbiota in Patients with Substance Use Disorders Revealed by 16S rRNA Gene Deep Sequencing.

Authors:  Yu Xu; Zhenrong Xie; Huawei Wang; Zongwen Shen; Youbing Guo; Yunhong Gao; Xin Chen; Qiang Wu; Xuejun Li; Kunhua Wang
Journal:  Sci Rep       Date:  2017-06-15       Impact factor: 4.379

7.  Mutual reinforcement of pathophysiological host-microbe interactions in intestinal stasis models.

Authors:  Ketrija Touw; Daina L Ringus; Nathaniel Hubert; Yunwei Wang; Vanessa A Leone; Anuradha Nadimpalli; Betty R Theriault; Yong E Huang; Johnathan D Tune; Paul B Herring; Gianrico Farrugia; Purna C Kashyap; Dionysios A Antonopoulos; Eugene B Chang
Journal:  Physiol Rep       Date:  2017-03

8.  Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease.

Authors:  Elena Barengolts; Stefan J Green; Yuval Eisenberg; Arfana Akbar; Bharathi Reddivari; Brian T Layden; Lara Dugas; George Chlipala
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

9.  Tolerance to Morphine-Induced Inhibition of TTX-R Sodium Channels in Dorsal Root Ganglia Neurons Is Modulated by Gut-Derived Mediators.

Authors:  Ryan A Mischel; William L Dewey; Hamid I Akbarali
Journal:  iScience       Date:  2018-04-27

Review 10.  Neuropsychiatric Disorders: Influence of Gut Microbe to Brain Signalling.

Authors:  Mary Scriven; Timothy G Dinan; John F Cryan; Mary Wall
Journal:  Diseases       Date:  2018-09-06
  10 in total
  10 in total

Review 1.  Gastrointestinal tract microbiota modifications in systemic sclerosis.

Authors:  Elizabeth R Volkmann; Anna-Maria Hoffmann-Vold
Journal:  Eur J Rheumatol       Date:  2019-12-19

Review 2.  Opioid Use, Gut Dysbiosis, Inflammation, and the Nervous System.

Authors:  Richa Jalodia; Yaa Fosuah Abu; Mark Ryan Oppenheimer; Bridget Herlihy; Jingjing Meng; Irina Chupikova; Junyi Tao; Nillu Ghosh; Rajib Kumar Dutta; Udhghatri Kolli; Yan Yan; Eridania Valdes; Madhulika Sharma; Umakant Sharma; Shamsudheen Moidunny; Sabita Roy
Journal:  J Neuroimmune Pharmacol       Date:  2022-01-07       Impact factor: 4.147

Review 3.  Effect of Opioid Use on Immune Activation and HIV Persistence on ART.

Authors:  Livio Azzoni; David Metzger; Luis J Montaner
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-25       Impact factor: 7.285

Review 4.  Drugs and Bugs: The Gut-Brain Axis and Substance Use Disorders.

Authors:  Sierra Simpson; Rio Mclellan; Emma Wellmeyer; Frederic Matalon; Olivier George
Journal:  J Neuroimmune Pharmacol       Date:  2021-10-25       Impact factor: 7.285

Review 5.  Less Well-Known Consequences of the Long-Term Use of Opioid Analgesics: A Comprehensive Literature Review.

Authors:  Aleksandra Kotlińska-Lemieszek; Zbigniew Żylicz
Journal:  Drug Des Devel Ther       Date:  2022-01-18       Impact factor: 4.162

Review 6.  The effect of opioids on gastrointestinal function in the ICU.

Authors:  Yun Yan; Yu Chen; Xijing Zhang
Journal:  Crit Care       Date:  2021-10-24       Impact factor: 9.097

Review 7.  Pain and Opioid-Induced Gut Microbial Dysbiosis.

Authors:  Karen R Thomas; Jacob Watt; Chuen Mong J Wu; Adejoke Akinrinoye; Sairah Amjad; Lucy Colvin; Rachel Cowe; Sylvia H Duncan; Wendy R Russell; Patrice Forget
Journal:  Biomedicines       Date:  2022-07-28

8.  Chronic opioid use modulates human enteric microbiota and intestinal barrier integrity.

Authors:  Angélica Cruz-Lebrón; Ramona Johnson; Claire Mazahery; Zach Troyer; Samira Joussef-Piña; Miguel E Quiñones-Mateu; Christopher M Strauch; Stanley L Hazen; Alan D Levine
Journal:  Gut Microbes       Date:  2021 Jan-Dec

Review 9.  On the Role of Peripheral Sensory and Gut Mu Opioid Receptors: Peripheral Analgesia and Tolerance.

Authors:  Susanna Fürst; Zoltán S Zádori; Ferenc Zádor; Kornél Király; Mihály Balogh; Szilvia B László; Barbara Hutka; Amir Mohammadzadeh; Chiara Calabrese; Anna Rita Galambos; Pál Riba; Patrizia Romualdi; Sándor Benyhe; Júlia Timár; Helmut Schmidhammer; Mariana Spetea; Mahmoud Al-Khrasani
Journal:  Molecules       Date:  2020-05-26       Impact factor: 4.411

10.  Opioid agonist and antagonist use and the gut microbiota: associations among people in addiction treatment.

Authors:  Rachel E Gicquelais; Amy S B Bohnert; Laura Thomas; Betsy Foxman
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.